Post COVID-19 Hypoxemic Respiratory Failure Residual Pathophysiologic Outcomes

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Covid-19
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Provide written consent form
    2. SARS-CoV-2 positive confirmed by a positive serology or PCR or antigen test
    3. COVID-19 induced hypoxemia or reduced oxygen saturation requiring treatment with supplemental oxygen
    4. COVID-19 hospital discharge date or outpatient COVID-19 infection within 24 weeks of enrollment

You may not be eligible for this study if the following are true:

    1. Diagnosed with Fibrotic Interstitial Lung Disease (ILD) prior to COVID-19 infection
    2. Prior treatment with an antifibrotic agent, including nintedanib or pirfenidone
    3. Pregnant women or women planning on becoming pregnant in the next 12 months
    4. Patients planned for discharge from the hospital to hospice
    5. Patients with significant cognitive impairment



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.